Document is current
Any future updates will be listed below
-
Authors
,
Matcham, F. http://orcid.org/0000-0002-4055-904X
Barattieri di San Pietro, C.
Bulgari, V.
de Girolamo, G.
Dobson, R.
Eriksson, H.
Folarin, A. A.
Haro, J. M.
Kerz, M.
Lamers, F.
Li, Q.
Manyakov, N. V.
Mohr, D. C.
Myin-Germeys, I.
Narayan, V.
BWJH, Penninx
Ranjan, Y.
Rashid, Z.
Rintala, A.
Siddi, S.
Simblett, S. K.
Wykes, T.
Hotopf, M.
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (115902)
- License Information
-
More Information
Article History
Received: 7 September 2018
Accepted: 1 February 2019
First Online: 18 February 2019
Consent for publication
: Not applicable.
: HE is a full-time employee of H. Lundbeck A/S and holds stock and stock optionsin H. Lundbeck A/S. QL, NM and VN are employees of Janssen Research & Development, LLC and hold company stocks/stock options. JMH has received economic compensation for participating in advisotry boards or giving educational lectures from Eli Lilly & Co, Sanofi, Lundbeck, and Otsuka. No other authors have competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
